Skip to main content
logo
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
38.87
-0.31 (-0.79%)
At close: Oct 30, 2026, 4:00 PM EDT
38.50
-0.37 (-0.95%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Nektar Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-157.13-164.08-118.96-276.06-368.2-523.84
Depreciation & Amortization
0.691.034.397.8213.0314.15
Loss (Gain) From Sale of Assets
---40.391.3-3.33-
Asset Writedown & Restructuring Costs
4.444.448.33111.8370.7116.7
Loss (Gain) on Equity Investments
3.958.73----
Stock-Based Compensation
11.9912.6521.6133.3957.3294.67
Other Operating Activities
-31.88-34.26-44.45-50.94-74.048.63
Change in Accounts Receivable
---3.054.7816.5112.4
Change in Inventory
--0.50.7-3.4-0.51
Change in Accounts Payable
10.61-0.632.67-2.883.1-11.69
Change in Other Net Operating Assets
-76.46-36.39-6.36-22.53-15.72-23.17
Operating Cash Flow
-233.79-208.51-175.71-192.61-304.01-412.66
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.94-0.87-1.47-0.87-5.68-14.99
Sale of Property, Plant & Equipment
---1.2513.2-
Investment in Securities
-844.16-0.3378.65139.18358.32217.77
Other Investing Activities
0.7-65.39---
Investing Cash Flow
-844.4-1.2142.57139.56365.84202.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-180.85----
Net Debt Issued (Repaid)
287.55180.85----
Issuance of Common Stock
5.580.870.120.030.7633.24
Repurchase of Common Stock
---3---
Other Financing Activities
781.34-1.1545-0.753
Financing Cash Flow
1,074180.5742.120.031.5136.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
00.01-00.06-0.33-0.09
Net Cash Flow
-3.72-29.148.98-52.9563.01-173.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-234.73-209.38-177.18-193.47-309.68-427.65
Free Cash Flow Growth
------
Free Cash Flow Margin
-429.99%-379.09%-180.01%-214.68%-336.41%-419.65%
Free Cash Flow Per Share
-9.66-12.41-12.92-15.27-24.82-35.00
Levered Free Cash Flow
-134.77-108.23-43.69-63.63-101.13-234.18
Unlevered Free Cash Flow
-115.41-91.86-26.12-47.8-83.06-204.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--0.20.082.660.270.33
Change in Working Capital
-65.85-37.02-6.24-19.940.49-22.97
SEC Filings: 10-K · 10-Q